Biomics Biopharma Limited 

Biomics Biopharma Limited, a near-clinical-stage biopharmaceutical company, researches, develops, and commercializes double stranded ribonucleic acid based products for unmet medical needs. The company offers CoSensia, an anti-acne skincare product that increases anti-inflammation cytokines and activates the natural immune responses, which suppress inflammation process; and Britena, a whitening and anti-blotch cream that uses small interfering ribonucleic acid (siRNA) to inhibit the formation of melanin in the skin. It also develops MultisiRNA, a siRNA-based therapeutic for the treatment of hepatitis B virus. The company was incorporated in 2016 and is based in Sydney, Australia.